Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets

F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …

Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents

VC Manganiello, E Degerman - Thrombosis and haemostasis, 1999 - thieme-connect.com
Cyclic adenosine 3'5'-monophosphate (cAMP) and cyclic guanosine 3'5'-monophoshpate
(cGMP) are critical intracellular second-messengers involved in the transduction of a wide …

Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents

C Lugnier - Pharmacology & therapeutics, 2006 - Elsevier
Cyclic nucleotide phosphodiesterases (PDEs), which are ubiquitously distributed in
mammalian tissues, play a major role in cell signaling by hydrolyzing cAMP and cGMP. Due …

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

AT Bender, JA Beavo - Pharmacological reviews, 2006 - ASPET
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels
of the second messengers, cAMP and cGMP, by controlling their rates of degradation. There …

Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions

SH Francis, MA Blount, JD Corbin - Physiological reviews, 2011 - journals.physiology.org
The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11
families of enzymes. PDEs break down cAMP and/or cGMP and are major determinants of …

Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities

A Samidurai, L Xi, A Das, AN Iness… - Pharmacology & …, 2021 - Elsevier
Cyclic nucleotide phosphodiesterases (PDEs) are superfamily of enzymes that regulate the
spatial and temporal relationship of second messenger signaling in the cellular system …

Advances in targeting cyclic nucleotide phosphodiesterases

DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …

Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives …

T Keravis, C Lugnier - British journal of pharmacology, 2012 - Wiley Online Library
Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular
messengers cAMP and cGMP in a compartmentalized manner represent an important …

[图书][B] Cyclic nucleotide phosphodiesterases in health and disease

J Beavo, SH Francis, MD Houslay - 2007 - api.taylorfrancis.com
The establishment of a Gordon Research Conference devoted to cyclic nucleotide
phosphodiesterases has had an enormous impact on the field by facilitating collaborations …

Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications

F Burns, AZ Zhao, JA Beavo - Advances in Pharmacology, 1996 - Elsevier
Publisher Summary The intracellular levels of cyclic nucleotides are regulated through
synthesis by adenylyl and guanylyl cyclases and also degradation by phosphodiesterases …